home.social

#pharmacokinetics — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #pharmacokinetics, aggregated by home.social.

fetched live
  1. Study reveals coffee triggers distinct cytokine responses compared with pure caffeine

    A controlled human study reveals that coffee’s complex chemical matrix may shape immune responses differently than pure caffeine,…
    #NewsBeep #News #Health #AU #Australia #Biomarker #Caffeine #Coffee #Cytokine #Cytokines #Interferon #Metabolism #Nutrition #Pharmacokinetics #Physiology #publichealth #research
    newsbeep.com/au/489828/

  2. Study reveals coffee triggers distinct cytokine responses compared with pure caffeine

    A controlled human study reveals that coffee’s complex chemical matrix may shape immune responses differently than pure caffeine,…
    #NewsBeep #News #Health #AU #Australia #Biomarker #Caffeine #Coffee #Cytokine #Cytokines #Interferon #Metabolism #Nutrition #Pharmacokinetics #Physiology #publichealth #research
    newsbeep.com/au/489828/

  3. Study reveals coffee triggers distinct cytokine responses compared with pure caffeine

    A controlled human study reveals that coffee’s complex chemical matrix may shape immune responses differently than pure caffeine,…
    #NewsBeep #News #Health #AU #Australia #Biomarker #Caffeine #Coffee #Cytokine #Cytokines #Interferon #Metabolism #Nutrition #Pharmacokinetics #Physiology #publichealth #research
    newsbeep.com/au/489828/

  4. Study reveals coffee triggers distinct cytokine responses compared with pure caffeine

    A controlled human study reveals that coffee’s complex chemical matrix may shape immune responses differently than pure caffeine,…
    #NewsBeep #News #Health #AU #Australia #Biomarker #Caffeine #Coffee #Cytokine #Cytokines #Interferon #Metabolism #Nutrition #Pharmacokinetics #Physiology #publichealth #research
    newsbeep.com/au/489828/

  5. The optimization of solvent osmolarity and viscosity in #Lymphatic Drug Delivery Systems (LDDS) significantly regulates drug #pharmacokinetics and perinodal dynamics to improve treatment of metastatic lymph nodes.
    #Biomedical #Pharmaceutical #Oncology #sflorg
    sflorg.com/2026/01/bmed0126260

  6. The optimization of solvent osmolarity and viscosity in #Lymphatic Drug Delivery Systems (LDDS) significantly regulates drug #pharmacokinetics and perinodal dynamics to improve treatment of metastatic lymph nodes.
    #Biomedical #Pharmaceutical #Oncology #sflorg
    sflorg.com/2026/01/bmed0126260

  7. The optimization of solvent osmolarity and viscosity in #Lymphatic Drug Delivery Systems (LDDS) significantly regulates drug #pharmacokinetics and perinodal dynamics to improve treatment of metastatic lymph nodes.
    #Biomedical #Pharmaceutical #Oncology #sflorg
    sflorg.com/2026/01/bmed0126260

  8. The optimization of solvent osmolarity and viscosity in #Lymphatic Drug Delivery Systems (LDDS) significantly regulates drug #pharmacokinetics and perinodal dynamics to improve treatment of metastatic lymph nodes.
    #Biomedical #Pharmaceutical #Oncology #sflorg
    sflorg.com/2026/01/bmed0126260

  9. The optimization of solvent osmolarity and viscosity in #Lymphatic Drug Delivery Systems (LDDS) significantly regulates drug #pharmacokinetics and perinodal dynamics to improve treatment of metastatic lymph nodes.
    #Biomedical #Pharmaceutical #Oncology #sflorg
    sflorg.com/2026/01/bmed0126260

  10. #FYI #rapamycin #alzheimers #pharmacokinetics

    "Rapamycin, an mTOR inhibitor used clinically for immunosuppression, shows promise for repurposing in age-related disorders including Alzheimer's disease (AD).
    This open-label pilot study investigated the pharmacokinetic properties of weekly oral rapamycin in [...] early-stage AD.
    Findings [...] support fixed-dose regimens in future trials."

    biologists.social/@medrxivprep

  11. #FYI #rapamycin #alzheimers #pharmacokinetics

    "Rapamycin, an mTOR inhibitor used clinically for immunosuppression, shows promise for repurposing in age-related disorders including Alzheimer's disease (AD).
    This open-label pilot study investigated the pharmacokinetic properties of weekly oral rapamycin in [...] early-stage AD.
    Findings [...] support fixed-dose regimens in future trials."

    biologists.social/@medrxivprep

  12. #FYI #rapamycin #alzheimers #pharmacokinetics

    "Rapamycin, an mTOR inhibitor used clinically for immunosuppression, shows promise for repurposing in age-related disorders including Alzheimer's disease (AD).
    This open-label pilot study investigated the pharmacokinetic properties of weekly oral rapamycin in [...] early-stage AD.
    Findings [...] support fixed-dose regimens in future trials."

    biologists.social/@medrxivprep

  13. #FYI #rapamycin #alzheimers #pharmacokinetics

    "Rapamycin, an mTOR inhibitor used clinically for immunosuppression, shows promise for repurposing in age-related disorders including Alzheimer's disease (AD).
    This open-label pilot study investigated the pharmacokinetic properties of weekly oral rapamycin in [...] early-stage AD.
    Findings [...] support fixed-dose regimens in future trials."

    biologists.social/@medrxivprep

  14. #FYI #rapamycin #alzheimers #pharmacokinetics

    "Rapamycin, an mTOR inhibitor used clinically for immunosuppression, shows promise for repurposing in age-related disorders including Alzheimer's disease (AD).
    This open-label pilot study investigated the pharmacokinetic properties of weekly oral rapamycin in [...] early-stage AD.
    Findings [...] support fixed-dose regimens in future trials."

    biologists.social/@medrxivprep

  15. i am using clobetasol sparingly (ok once a day) but it is helping me creep back to semi normalcy? I have used a bevy of other topical steroids and you have to be really careful not to go over the line - one minute it is helping and next minute it is hell...there are a plethora of monoclonal Ab peptides on the way with v good 3rd stage trials results; no miracle cures yet for psoriasis, i think they are still drilling down a bit and all various interleukins/pathways #il23 #pharmacokinetics

  16. i am using clobetasol sparingly (ok once a day) but it is helping me creep back to semi normalcy? I have used a bevy of other topical steroids and you have to be really careful not to go over the line - one minute it is helping and next minute it is hell...there are a plethora of monoclonal Ab peptides on the way with v good 3rd stage trials results; no miracle cures yet for psoriasis, i think they are still drilling down a bit and all various interleukins/pathways #il23 #pharmacokinetics

  17. i am using clobetasol sparingly (ok once a day) but it is helping me creep back to semi normalcy? I have used a bevy of other topical steroids and you have to be really careful not to go over the line - one minute it is helping and next minute it is hell...there are a plethora of monoclonal Ab peptides on the way with v good 3rd stage trials results; no miracle cures yet for psoriasis, i think they are still drilling down a bit and all various interleukins/pathways #il23 #pharmacokinetics

  18. A unifying #model to explain frequent #SARS-CoV-2 #rebound after #nirmatrelvir #treatment and limited prophylactic #efficacy nature.com/articles/s41467-024

    Here authors develop a mathematical model for viral-immune dynamics & nirmatrelvir #pharmacokinetics and suggest that early treatment preserves susceptible cells & blunts innate immune response without fully eliminating infection. They project that treatment extension for 10 days may overcome this effect.

  19. A unifying #model to explain frequent #SARS-CoV-2 #rebound after #nirmatrelvir #treatment and limited prophylactic #efficacy nature.com/articles/s41467-024

    Here authors develop a mathematical model for viral-immune dynamics & nirmatrelvir #pharmacokinetics and suggest that early treatment preserves susceptible cells & blunts innate immune response without fully eliminating infection. They project that treatment extension for 10 days may overcome this effect.

  20. A unifying #model to explain frequent #SARS-CoV-2 #rebound after #nirmatrelvir #treatment and limited prophylactic #efficacy nature.com/articles/s41467-024

    Here authors develop a mathematical model for viral-immune dynamics & nirmatrelvir #pharmacokinetics and suggest that early treatment preserves susceptible cells & blunts innate immune response without fully eliminating infection. They project that treatment extension for 10 days may overcome this effect.

  21. A unifying #model to explain frequent #SARS-CoV-2 #rebound after #nirmatrelvir #treatment and limited prophylactic #efficacy nature.com/articles/s41467-024

    Here authors develop a mathematical model for viral-immune dynamics & nirmatrelvir #pharmacokinetics and suggest that early treatment preserves susceptible cells & blunts innate immune response without fully eliminating infection. They project that treatment extension for 10 days may overcome this effect.

  22. A unifying #model to explain frequent #SARS-CoV-2 #rebound after #nirmatrelvir #treatment and limited prophylactic #efficacy nature.com/articles/s41467-024

    Here authors develop a mathematical model for viral-immune dynamics & nirmatrelvir #pharmacokinetics and suggest that early treatment preserves susceptible cells & blunts innate immune response without fully eliminating infection. They project that treatment extension for 10 days may overcome this effect.

  23. Residence time (Ecology 🏞️)

    The residence time of a fluid parcel is the total time that the parcel has spent inside a control volume. The residence time of a set of parcels is quantified in terms of the frequency distribution of the residence time in the set, which is known as residence time distribution, or in terms of its average, known as mean reside...

    en.wikipedia.org/wiki/Residenc

    #ResidenceTime #Ecology #Geochemistry #QueueingTheory #Pharmacokinetics #BiogeochemicalCycle

  24. Dear #psychiatry folks, do any of you know of a resident or faculty doc interested in #lithium #pharmacokinetics whom I could suggest to the journal as a possible reviewer for the world's shortest article? They're having trouble finding anyone. Thanks. The article is free at
    f1000research.com/articles/11-

  25. Dear #psychiatry folks, do any of you know of a resident or faculty doc interested in #lithium #pharmacokinetics whom I could suggest to the journal as a possible reviewer for the world's shortest article? They're having trouble finding anyone. Thanks. The article is free at
    f1000research.com/articles/11-

  26. What this boils down to is using mathematical/statistical models to help explain and predict what the body does to the drug (#Pharmacokinetics, #PK) and what the drug does to the body (#Pharmacodynamics, #PD) - these are often combined to produce #PKPD or #ExposureResponse models.

  27. What this boils down to is using mathematical/statistical models to help explain and predict what the body does to the drug (#Pharmacokinetics, ) and what the drug does to the body (#Pharmacodynamics, ) - these are often combined to produce or models.

  28. What this boils down to is using mathematical/statistical models to help explain and predict what the body does to the drug (#Pharmacokinetics, #PK) and what the drug does to the body (#Pharmacodynamics, #PD) - these are often combined to produce #PKPD or #ExposureResponse models.

  29. What this boils down to is using mathematical/statistical models to help explain and predict what the body does to the drug (#Pharmacokinetics, #PK) and what the drug does to the body (#Pharmacodynamics, #PD) - these are often combined to produce #PKPD or #ExposureResponse models.

  30. What this boils down to is using mathematical/statistical models to help explain and predict what the body does to the drug (#Pharmacokinetics, #PK) and what the drug does to the body (#Pharmacodynamics, #PD) - these are often combined to produce #PKPD or #ExposureResponse models.

  31. Pharmacometrics rolls up modeling and simulation for #Pharmacokinetics, #Pharmacodynamics, and #DiseaseProgression, with a focus on populations and variability. A major focus is to understand variability in drug response, which can be predictable (e.g. due to differences in body weight or kidney function) or unpredictable (differences between subjects seem random, but likely reflect a lack of knowledge or data).

    en.wikipedia.org/wiki/Pharmaco

  32. Pharmacometrics rolls up modeling and simulation for , , and , with a focus on populations and variability. A major focus is to understand variability in drug response, which can be predictable (e.g. due to differences in body weight or kidney function) or unpredictable (differences between subjects seem random, but likely reflect a lack of knowledge or data).

    en.wikipedia.org/wiki/Pharmaco

  33. Pharmacometrics rolls up modeling and simulation for #Pharmacokinetics, #Pharmacodynamics, and #DiseaseProgression, with a focus on populations and variability. A major focus is to understand variability in drug response, which can be predictable (e.g. due to differences in body weight or kidney function) or unpredictable (differences between subjects seem random, but likely reflect a lack of knowledge or data).

    en.wikipedia.org/wiki/Pharmaco

  34. Pharmacometrics rolls up modeling and simulation for #Pharmacokinetics, #Pharmacodynamics, and #DiseaseProgression, with a focus on populations and variability. A major focus is to understand variability in drug response, which can be predictable (e.g. due to differences in body weight or kidney function) or unpredictable (differences between subjects seem random, but likely reflect a lack of knowledge or data).

    en.wikipedia.org/wiki/Pharmaco

  35. Pharmacometrics rolls up modeling and simulation for #Pharmacokinetics, #Pharmacodynamics, and #DiseaseProgression, with a focus on populations and variability. A major focus is to understand variability in drug response, which can be predictable (e.g. due to differences in body weight or kidney function) or unpredictable (differences between subjects seem random, but likely reflect a lack of knowledge or data).

    en.wikipedia.org/wiki/Pharmaco